Acadian Asset Management LLC Applied Genetic Technologies Corp Transaction History

Acadian Asset Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$3.94 - $8.19 $1.1 Million - $2.29 Million	-279,668 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$3.99 - $5.7 $321,645 - $459,494	-80,613 Reduced 22.38%	279,668 $1.14 Million
Q3 2020 Nov 09, 2020	SELL	$4.38 - $6.43 $1.58 Million - $2.33 Million	-361,826 Reduced 50.11%	360,281 $1.75 Million
Q2 2020 Aug 12, 2020	SELL	$3.0 - $6.9 $454,290 - $1.04 Million	-151,430 Reduced 17.34%	722,107 $4 Million
Q1 2020 May 11, 2020	BUY	$2.36 - $9.86 $398,089 - $1.66 Million	168,682 Added 23.93%	873,537 $2.87 Million
Q4 2019 Feb 06, 2020	BUY	$2.69 - $4.92 $13,363 - $24,442	4,968 Added 0.71%	704,855 $3.18 Million
Q3 2019 Nov 07, 2019	BUY	$2.59 - $4.16 $1.81 Million - $2.91 Million	699,887 New	699,887 $2.91 Million
Q2 2019 Aug 08, 2019	SELL	$3.6 - $4.78 $2.51 Million - $3.34 Million	-698,053 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$2.62 - $4.44 $61,043 - $103,447	23,299 Added 3.45%	698,053 $2.93 Million
Q4 2018 Feb 07, 2019	SELL	$2.28 - $7.15 $29,521 - $92,578	-12,948 Reduced 1.88%	674,754 $1.68 Million
Q3 2018 Oct 30, 2018	BUY	$3.85 - $7.35 $3,734 - $7,129	970 Added 0.14%	687,702 $5.02 Million
Q2 2018 Jul 24, 2018	SELL	$3.7 - $5.65 $15,369 - $23,470	-4,154 Reduced 0.6%	686,732 $2.54 Million
Q1 2018 Apr 12, 2018	BUY	$3.65 - $5.2 $42,829 - $61,016	11,734 Added 1.73%	690,886 $2.66 Million
Q4 2017 Jan 18, 2018	SELL	$3.4 - $4.15 $44,353 - $54,136	-13,045 Reduced 1.88%	679,152 $2.45 Million
Q3 2017 Oct 13, 2017	BUY	$3.55 - $5.25 $2.46 Million - $3.63 Million	692,197	692,197 $2.73 Million

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.